AMUNDI ASSET MANAGEMENT US, INC. - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 177 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.

Quarter-by-quarter ownership
AMUNDI ASSET MANAGEMENT US, INC. ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$313,000
-25.1%
7,3000.0%0.00%
Q4 2020$418,000
+90.0%
7,3000.0%0.00%
Q3 2020$220,000
+86.4%
7,300
+102.8%
0.00%
Q2 2020$118,000
+76.1%
3,600
+44.0%
0.00%
Q1 2020$67,000
+45.7%
2,500
+66.7%
0.00%
Q4 2019$46,000
+27.8%
1,5000.0%0.00%
Q3 2019$36,0001,5000.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders